Effect of Homogenization and Pasteurization of Milk on the Stomach Problems in Adults
1 other identifier
interventional
11
1 country
1
Brief Summary
This study aims to investigate differences in digestion rates and stomach problems caused by pasteurized and homogenized milk compared with raw milk in healthy adults by ingestible capsule that measures pH and pressure, diary of symptoms, blood glucose and triacylglycerol levels and plasma cytokine levels.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2014
CompletedFirst Submitted
Initial submission to the registry
August 14, 2014
CompletedFirst Posted
Study publicly available on registry
August 18, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2018
CompletedJanuary 16, 2018
January 1, 2018
1.6 years
August 14, 2014
January 12, 2018
Conditions
Outcome Measures
Primary Outcomes (2)
Pressure in the intestinal tract
Pressure in the intestinal tract as measured by ingestible Smart Pill -capsule.
Day 0 - Day 5
Gastrointestinal symptoms (self-reported)
Gastrointestinal symptoms (self-reported) as measured by a questionnaire. The questionnaire is devided into seven types of stomach discomfort, and also includes a possibility to describe a stomach discomfort outside these seven given alternatives. The severity of the symptoms is self-reported on a three-step scale.
Day 0 - Day 5
Secondary Outcomes (4)
Plasma triacylglycerols
20min, 40min, 60min, 120min, 180min, 240min
Plasma glucose
20min, 40min, 60min, 90min, 120min, 180min, 240min
Plasma triacylglycerols
20min, 40min, 60min, 90min, 120min, 180min, 240min
Plasma insulin
20min, 40min, 60min, 90min, 120min, 180min, 240min
Study Arms (2)
Homogenized and pasteurized milk
EXPERIMENTALMilk that has undergone homogenization ans pasteurization treatment
Nonhomogenized and nonpasteurized milk
EXPERIMENTALUnhomogenized and unpasteurized milk (raw milk)
Interventions
Eligibility Criteria
You may qualify if:
- Homogenized and pasteurized milk causes stomach problems (self-reported)
- unhomogenized and unpasteurized milk does not cause stomach problems (self-reported)
- age 18-65
- BMI 18,5 - 30
- hemoglobin under normal range
- fasting plasma alanine aminotransferase ALAT \< 60 U/l (normal liver function)
- fasting plasma thyroid-stimulating hormone (TSH) 0.4 - 4.5 mU/l (normal thyroid function)
- fasting plasma creatinine \< 118 umol/l (normal kidney function)
You may not qualify if:
- pace maker
- Crohn's disease or other disease of the intestinal tract
- intestinal operation within the last 3 months
- difficult dysphagia
- smoking
- constipation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Biochemistry University of Turku
Turku, 20014, Finland
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kaisa M Linderborg, PhD
University of Turku
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD, Adjunct professor
Study Record Dates
First Submitted
August 14, 2014
First Posted
August 18, 2014
Study Start
August 1, 2014
Primary Completion
March 1, 2016
Study Completion
January 1, 2018
Last Updated
January 16, 2018
Record last verified: 2018-01